UBC-grown biotech companies lead global pandemic efforts

Posted onApril 26, 2021

Millions of Canadians have received the Pfizer-BioNTech COVID-19 vaccine, but what many may not realize is that a key component of the injection was developed right here at UBC.

Acuitas Therapeutics, a UBC spin-off company co-founded by Dr. Pieter Cullis, developed the lipid nanoparticle technology that allows the Pfizer-BioNTech mRNA vaccine to enter human cells….

https://news.ubc.ca/2021/04/26/ubc-grown-biotech-companies-lead-global-pandemic-efforts

Spinal cord injury: stimulating neural plasticity to improve walking

This article is only available in French. Lésion de la moelle épinière: stimuler la plasticité des neurones pour améliorer la [...]

Posted onJanuary 24, 2024

Unraveling the complexity of betacoronaviruses in bats

A comprehensive study by scientists at UdeM maps the evolutionary dynamics and risks of viral emergence of diseases that could [...]

Posted onJanuary 24, 2024

Respiratory infections: better patient triage to relieve pressure on emergency departments

This article is available only in French. Infections respiratoires: mieux trier les patients pour soulager la pression sur les urgences [...]

UBC-grown biotech companies lead global pandemic efforts

Read More Impact Stories

Spinal cord injury: stimulating neural plasticity to improve walking

Unraveling the complexity of betacoronaviruses in bats

Respiratory infections: better patient triage to relieve pressure on emergency departments